PDGFRB and myeloid sarcoma: Likewise, we detected increased perivascular aggregates of PDGFRβ+ cells accompanied by gliosis in post-mortem spinal cord samples from six patients diagnosed with chronic MS (secondary progressive MS type), who survived for 17–56 years after the disease onset (Supplementary Table 2, Fig. 10c–f).